Hemoglobin adducts in 1,3-butadiene exposed Czech workers: Female-male comparisons

Chemico-Biological Interactions

Volumn 188, Issue 3, 2010, Pages 668-676

  Vacek, Pamela M ^a   Albertini, Richard J ^a   Sram, Radim J ^b   Upton, Patricia ^c   Swenberg, James A ^c  

^a UNIVERSITY OF VERMONT   (United States)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

1,3 Butadiene; M1 urine metabolite; M2 urine metabolite; Metabolism; Molecular epidemiology; THB Val hemoglobin adducts

Indexed keywords

1 HYDROXY 2 (N ACETYLCYSTEINYL) 3 BUTENE; 1,2 DIHYDROXY 3,4 EPOXYBUTANE; 1,3 BUTADIENE; 2 HYDROXY 1 (N ACETYLCYSTEINYL) 3 BUTENE; ALKENE; BUTANE; HEMOGLOBIN; N (2,3,4 TRIHYDROXY BUTYL)VALINE; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME ABERRATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOGENETICS; CZECH REPUBLIC; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEMOGLOBIN DETERMINATION; HUMAN; HUMAN CELL; MALE; METABOLITE; MUTATIONAL ANALYSIS; OCCUPATIONAL EXPOSURE; SEX DIFFERENCE; SOMATIC MUTATION; URINALYSIS;

BUTADIENES; CHROMOSOME ABERRATIONS; CZECH REPUBLIC; ENVIRONMENTAL EXPOSURE; FEMALE; GENOTYPE; HEMOGLOBINS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MALE; MUTATION; SEX CHARACTERISTICS; SEX FACTORS; SMOKING; VOLATILIZATION;

RODENTIA;

EID: 78149471572     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cbi.2010.06.017     Document Type: Article

References (56)

1. Huff J.E., Melnick R.L., Solleveld H.A., Haseman J.K., Powers M., Miller R.A. Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science 1985, 227:548-549.
2. Melnick R.L., Huff J., Chou B.J., Miller R.A. Carcinogenicity of 1,3-butadiene in C57BL/6×C3H F1 mice at low exposure concentrations. Cancer Res 1990, 50:6592-6599.
3. National Toxicology Program Toxicology and carcinogenesis studies of 1,3-butadiene in B6C3F1 mice (inhalation studies). NTP Tech. Rep. 1993, 434.
4. Owen P.E., Glaister J.R., Gaunt I.F., Pullinger D.H. Inhalation toxicity studies with 1,3-butadiene. 3. Two year toxicity/carcinogenicity study in rats. Am. Ind. Hyg. Assoc. J. 1987, 48:407-413.
5. Goggin M., Swenberg J.A., Walker V.E., Tretyakova N. Molecular dosimetry of 1,2,3,4-diepoxybutane-induced DNA-DNA cross-links in B6C3F1 mice and F344 rats exposed to 1,3-butadiene by inhalation. Cancer Res. 2009, 69:2479-2486.
6. Meng Q., Walker D.M., McDonald J.D., Henderson R.F., Carter M.M., Cook D.L., McCash C.L., Torres S.M., Bauer M.J., Seilkop S.K., Upton P.B., Georgieva N.I., Boysen G., Swenberg J.A., Walker V.E. Age-, gender-, and species-dependent mutagenicity in T cells of mice and rats exposed by inhalation to 1,3-butadiene. Chem. Biol. Interact. 2007, 166:121-131.
7. Boysen G., Georgieva N.I., Upton P.B., Walker V.E., Swenberg J.A. N-terminal globin adducts as biomarkers for formation of butadiene-derived epoxides. Chem. Biol. Interact. 2007, 166:84-92.
8. Georgieva N.I., Boysen G., Bordeerat N., Walker V.E., Swenberg J.A. Exposure-response of 1,2,3,4-diepoxybutand specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene. Toxicol. Sci. 2010, (Advance Epub February 22, 2010).
9. Matanoski G.M., Santos-Burgoa C., Schwartz L. Mortality of a cohort of workers in the styrene-butadiene polymer manufacturing industry (1943-1982). Environ. Health Perspect. 1990, 86:107-117.
10. Straif K., Weiland S.K., Werner B., Chambless L., Mundt K.A., Keil.U. Workplace risk factors for cancer in the German rubber industry. Part 2. Mortality from non-respiratory cancers. Occup. Environ. Med. 1998, 55:325-332.
11. Sathiakumar N., Graff J., Macaluso M., Maldonado G., Matthews R., Delzell E. An updated study of mortality among North American synthetic rubber industry workers. Occup. Environ. Med. 2005, 62:822-829.
12. Cheng H., Sathiakumar N., Graff J., Matthews R., Delzell E. 1,3-Butadiene and leukemia among synthetic rubber industry workers: exposure-response relationships. Chem. Biol. Interact. 2007, 1-3:15-24.
13. Clapp R.W., Jacobs M.M., Loechler E.L. Environmental and occupational causes of cancer: new evidence 2005-2007. Rev. Environ. Health 2008, 23:1-37.
14. Whitworth K.W., Symanski E., Coker A.L. Childhood lymphohematopoietic cancer incidence and hazardous air pollutants in southwest Texas, 1995-2004. Environ. Health Perspect. 2008, 116:1576-1580.
15. Graff J.J., Sathiakumar N., Macaluso M., Maldonado G., Matthews R., Delzell E. Chemical exposures in the synthetic rubber industry and lymphohematopoietic cancer mortality. J. Occup. Environ. Med. 2005, 47:916-932.
16. Delzell E., Sathiakumar N., Graff J., Macaluso M., Maldonado G., Matthews R. An updated study of mortality among North American synthetic rubber industry workers. Res. Rep. Health Eff. Inst. 2006, 132:1-63.
17. Cole P., Delzell E., Acquavella J. Exposure to butadiene and lymphatic and hematopoietic cancer. Epidemiology 1993, 4:96-103.
18. Divine B.J., Hartman C.M. A cohort mortality study among workers at a 1,3 butadiene facility. Chem. Biol. Interact. 2001, 135-136:535-553.
19. Sielken R.L., Valdez-Flores C., Gargas M.L., Kirman C.R., Teta M.J., Delzell E. Cancer risk assessment for 1,3-butadiene: dose-response modeling from an epidemiological perspective. Chem. Biol. Interact. 2007, 166:140-149.
20. ATSDR Toxicological Profile for 1,3-Butadiene 1993.
21. U.S.Environmental Protection Agency Health Assessment of 1,3-Butadiene 2002, National Center for Environmental Assessment, Washington, DC.
22. National Toxicology Program Report on Carcinogens 2005, U.S. Department of Health and Human Services, Public Health Service, National Toxicology Program, Washington, DC. eleventh edition.
23. IARC 1.3-Butadiene, Ethylene Oxide and Vinyl Halides (Vinyl Fluoride, Vinyl Chloride and Vinyl Bromide) 2008.
24. Legator M.S., Au W.W., Ammenheuser M., Ward J.B. Elevated somatic cell mutant frequencies and altered DNA repair responses in nonsmoking workers exposed to 1,3-butadiene. IARC Sci. Publ. 1993, 253-263.
25. Ward J.B., Ammenheuser M.M., Bechtold W.E., Whorton E.B., Legator M.S. HPRT mutant lymphocyte frequencies in workers at a 1,3-butadiene production plant. Environ. Health Perspect. 1994, 102:79-85.
26. Ward J.B., Ammenheuser M.M., Whorton E.B., Bechtold W.E., Kelsey K.T., Legator M.S. Biological monitoring for mutagenic effects of occupational exposure to butadiene. Toxicology 1996, 113:84-90.
27. Ward J.B., Ammenheuser M.M., Bechtold W.E., Hastings D.A., Legator M.S. Biological monitoring of occupational exposures to 1,3-butadiene. Toxicologist 1997, 36:305.
28. Ammenheuser M.M., Bechtold W.E., Abdel-Rahman S.Z., Rosenblatt J.I., Hastings-Smith D.A., Ward J.B. Assessment of 1,3-butadiene exposure in polymer production workers using HPRT mutations in lymphocytes as a biomarker. Environ. Health Perspect. 2001, 109:1249-1255.
29. Ward J.B., Abdel-Rahman S.Z., Henderson R.F., Stock T.H., Morandi M., Rosenblatt J.I., Ammenheuser M.M. Assessment of butadiene exposure in synthetic rubber manufacturing workers in Texas using frequencies of HPRT mutant lymphocytes as a biomarker. Chem. Biol. Interact. 2001, 135-136:465-483.
30. Wickliffe J.K., Ammenheuser M.M., Adler P.J., Abdel-Rahman S.Z., Ward J.B. Evaluation of frequencies of HPRT mutant lymphocytes in butadiene polymer workers in a Southeast Texas facility. Environ. Mol. Mutagen 2009, 50:82-87.
31. Hayes R.B., Xi L., Bechtold W.E., Rothman N., Yao M., Henderson R., Zhang L., Smith M.T., Zhang D., Wiemels J., Dosemeci M., Yin S., O'Neill J.P. HPRT mutation frequency among workers exposed to 1,3-butadiene in China. Toxicology 1996, 113:100-105.
32. Hayes R.B., Zhang L., Yin S., Swenberg J.A., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Zhang D., Wiemels J., Dosemeci M., Li G., Smith M.T. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis 2000, 21:55-62.
33. Hayes R.B., Zhang L., Swenberg J.A., Yin S.N., Xi L., Wiencke J., Bechtold W.E., Yao M., Rothman N., Haas R., O'Neill J.P., Wiemels J., Dosemeci M., Li G., Smith M.T. Markers for carcinogenicity among butadiene-polymer workers in China. Chem. Biol. Interact. 2001, 135-136:455-464.
34. Zhang L., Hayes R.B., Guo W., McHale C.M., Yin S., Wiencke J.K., Patrick O.J., Rothman N., Li G.L., Smith M.T. Lack of increased genetic damage in 1,3-butadiene-exposed Chinese workers studied in relation to EPHX1 and GST genotypes. Mutat. Res. 2004, 558:63-74.
35. Liu S., Ao L., Du B., Zhou Y., Yuan J., Bai Y., Zhou S., Cao.J. HPRT mutations in lymphocytes from 1,3-butadiene-exposed workers in China. Environ. Health Perspect. 2008, 116:203-208.
36. Fustinoni S., Soleo L., Warholm M., Begemann P., Rannug A., Neumann H.G., Swenberg J.A., Vimercati L., Colombi A. Influence of metabolic genotypes on biomarkers of exposure to 1,3-butadiene in humans. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1082-1090.
37. Fustinoni S., Perbellini L., Soleo L., Manno M., Foa.V. Biological monitoring in occupational exposure to low levels of 1,3-butadiene. Toxicol. Lett. 2004, 149:353-360.
38. Lovreglio P., Bukvic N., Fustinoni S., Ballini A., Drago I., Foa V., Guanti G., Soleo L. Lack of genotoxic effect in workers exposed to very low doses of 1,3-butadiene. Arch. Toxicol. 2006, 80:378-381.
39. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Wright M., Nicklas J.A., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B. Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem. Biol. Interact 2001, 135-136:429-453.
40. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Nicklas J.A., van Sittert N.J., Boogaard P.J., Henderson R.F., Swenberg J.A., Tates A.D., Ward J.B., Wright M., et al. Biomarkers in Czech workers exposed to 1,3-butadiene: a transitional epidemiologic study. Res. Rep.Health Eff. Inst. 2003, 116.
41. Albertini R.J., Sram R.J., Vacek P.M., Lynch J., Rossner P., Nicklas J.A., McDonald J.D., Boysen G., Georgieva N., Swenberg J.A. Molecular epidemiological studies in 1,3-butadiene exposed Czech workers: female-male comparisons. Chem. Biol. Interact. 2007, 166:63-77.
42. Gowans E.M., Fraser C.G. Biological variation in analyte concentrations in urine of apparently healthy men and women. Clin Chem 1989, 33:847-850.
43. Törnqvist M., Mowrer J., Jensen S., Ehrenberg L. Monitoring of environmental cancer initiators through hemoglobin adducts by a modified Edman degradation method. Anal Biochem 1986, 154:255-266.
44. Pérez H.L., Lähdetie J., Landin H.H., Kilpelainen I., Koivisto P., Peltonen K., Osterman-Golkar S. Haemoglobin adducts of epoxybutanediol from exposure to 1,3-butadiene or butadiene epoxides. Chem. Biol. Interact. 1997, 105:181-198.
45. Törnqvist M. Epoxide adducts to N-terminal valine of hemoglobin. Methods Enzymol. 1994, 231:650-657.
46. McDonald J.D., Bechtold W.E., Krone J.R., Blackwell W.B., Kracko D.A., Henderson R.F. Analysis of butadiene urinary metabolites by liquid chromatography/triple quadruple mass spectrometry. J. Anal. Toxicol. 2004, 28:168-173.
47. O'Neill J.P., McGinniss M.J., Berman J.K., Sullivan L.M., Nicklas J.A., Albertini R.J. Refinement of a T-lymphocyte cloning assay to quantify the in vivo thioguanine-resistant mutant frequency in humans. Mutagenesis 1987, 2:87-94.
48. Rubes J., Kucharova S., Vozdova M., Musilova P., Zudova Z. Cytogenetic analysis of peripheral lymphocytes in medical personnel by means of FISH. Mutation Res. 1998, 412:293-298.
49. Tucker J.D., Morgan W.F., Awa A.A., Bauchinger M., Blakey D., Comforth M.N., Littlefield L.G., Natarajan A.T., Shasserre G. A proposed system for scoring structural aberrations detected by chromosome painting. Cytogenet. Cell Genet. 1995, 68:211-221.
50. Lucas D., Poggenesee M., Straume T. Translocation between two specific human chromosomes detected by three-color " chromosome painting" Cytogenet. Cell Genet. 1993, 62:11.
51. Himmelstein M.W., Acquavella J.F., Recio L., Medinsky M.A., Bond.J.A. Toxicology and epidemiology of 1,3-butadiene. Crit. Rev. Toxicol. 1997, 27:1-108.
52. 2-propanodeoxyguanosine adducts of the 1,3-butadiene metabolite, hydorxymethylvinyl ketone. Chem. Res. Toxicol. 2003, 16:1448-1454.
53. Cochrane J.E., Skopek T.R. Mutagenicity of butadiene and its epoxide metabolites. I. mutagenic potential of 1,2 epoxybutene, 1,2,3,4-dieoxybutane and 3,4-epoxy-1,2-butanediol in cultured human lymphoblasts. Carcinogenesis 1994, 15:713-717.
54. Meng Q., Redetzke D.L., Hackfeld L.C., Hodge R.P., Walker D.M., Walker V.E. Mutagenicity of stereochemical configurations of 1,2-epoxybutene and 1,2,3,4-diepoxybutane in human lymphoblastoid cells. Chem. Biol. Interact. 2007, 166:207-218.
55. Swenberg J.A., Boysen G., Georgieva N., Bird M.G., Lewis R.J. Future directions in butadiene risk assessment and the role of cross-species internal dosimetry. Chem. Biol. Interact. 2007, 166:78-83.
56. Fred C., Tornqvist M., Granath F. Evaluation of cancer tests of 1,3-butadiene using internal dose, genotoxic potency, and a multiplicative risk model. Cancer Res. 2008, 68:8014-8021.